Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Nancy Denyes currently holds 33,124 shares of aTYR PHARMA INC (LIFE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nancy Denyes has been a net buyer of LIFE stock. They have purchased $9.3K and sold $2.3K worth of shares.
Nancy Denyes's most recent insider trade was on Feb 4, 2026, when they sold 1,118 shares at $0.98 per share.
Nancy Denyes serves as Executive at aTYR PHARMA INC (LIFE). They have executed 11 insider transactions totaling $11.6K over their tenure at the company.
Nancy Denyes holds the position of Executive at aTYR PHARMA INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Nancy Denyes has shown a buying trading pattern, with $9.3K in total purchases and $2.3K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Nancy Denyes was on Jun 5, 2024, when they purchased $9.3K worth of ATYR shares. This transaction involved 5,000 shares at $1.86 per share.
Nancy Denyes currently owns 33,124 shares of aTYR PHARMA INC (LIFE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Nancy Denyes's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Nancy Denyes has 11 Form 4 filings on record as an insider at aTYR PHARMA INC.
Set alerts for Nancy Denyes and 40,000+ other insiders.